Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | QPCT | Q16769 | 1/20 | 0.37 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.37 |
| ▸ | RORC | P51449 | 2/20 | 0.37 |
| ▸ | RORB | Q92753 | 2/20 | 0.37 |
| ▸ | TUBB4A | P04350 | 12/20 | 0.36 |
| ▸ | TUBB | P07437 | 12/20 | 0.36 |
| ▸ | TUBA3C | P0DPH7 | 12/20 | 0.36 |
| ▸ | TUBA1B | P68363 | 12/20 | 0.36 |
| ▸ | TUBA4A | P68366 | 12/20 | 0.36 |
| ▸ | TUBB4B | P68371 | 12/20 | 0.36 |
| ▸ | TUBB3 | Q13509 | 12/20 | 0.36 |
| ▸ | TUBB2A | Q13885 | 12/20 | 0.36 |
| ▸ | TUBB8 | Q3ZCM7 | 12/20 | 0.36 |
| ▸ | TUBA3E | Q6PEY2 | 12/20 | 0.36 |
| ▸ | TUBA1A | Q71U36 | 12/20 | 0.36 |
| ▸ | TUBA1C | Q9BQE3 | 12/20 | 0.36 |
| ▸ | TUBB6 | Q9BUF5 | 12/20 | 0.36 |
| ▸ | TUBB2B | Q9BVA1 | 12/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1882946 | 0.86 | KDM4E (0.43) | PTGES2QPCTQPCTL | |
| SCHEMBL2493441 | 0.86 | PTGES2 (0.40) | PTGES2QPCTQPCTLTUBB4ATUBB | |
| SCHEMBL2493951 | 0.86 | PTGES2 (0.39) | PTGES2QPCTQPCTLTUBB4ATUBB | |
| SCHEMBL2495295 | 0.85 | HTR7 (0.44) | CNR2RORCRORBTUBB4ATUBB | |
| SCHEMBL2499271 | 0.85 | PDE10A (0.40) | PTGES2QPCTQPCTLTUBB4ATUBB | |
| SCHEMBL2499463 | 0.85 | PTGES2 (0.41) | PTGES2QPCTQPCTL | |
| SCHEMBL2498117 | 0.84 | PDE10A (0.41) | PTGES2QPCTQPCTLTUBB4ATUBB | |
| SCHEMBL2494691 | 0.84 | KDM4E (0.43) | PTGES2CNR2QPCTQPCTLTUBB4A | |
| SCHEMBL2498249 | 0.83 | ESRRA (0.44) | CNR2RORBTUBB4ATUBBTUBA3C | |
| SCHEMBL2500063 | 0.83 | TUBB4A (0.39) | PTGES2QPCTQPCTLTUBB4ATUBB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8030339-B2 | Imidazole derivatives for the treatment of anxiety and related diseases | NEUROSEARCH A/S (DK) | 2011-10-04 | — | — | US | claimed |
| US-20090233929-A1 | Imidazole Derivatives for the Treatment of Anxiety and Related Diseases | NEUROSEARCH A/S (DK) | 2009-09-17 | — | — | US | claimed |
| EP-1937649-A1 | IMIDAZOLE DERIVATIVES FOR THE TREATMENT OF ANXIETY AND RELATED DISEASES | NEUROSEARCH A/S (DK) | 2008-07-02 | — | — | EP | claimed |
| WO-2007042546-A1 | IMIDAZOLE DERIVATIVES FOR THE TREATMENT OF ANXIETY AND RELATED DISEASES | NEUROSEARCH A/S (DK) | 2007-04-19 | — | — | WO | claimed |
| US-8030339-B2 | Imidazole derivatives for the treatment of anxiety and related diseases | NEUROSEARCH A/S (DK) | 2011-10-04 | — | — | US | disclosed |
| US-20090233929-A1 | Imidazole Derivatives for the Treatment of Anxiety and Related Diseases | NEUROSEARCH A/S (DK) | 2009-09-17 | — | — | US | disclosed |
| EP-1937649-A1 | IMIDAZOLE DERIVATIVES FOR THE TREATMENT OF ANXIETY AND RELATED DISEASES | NEUROSEARCH A/S (DK) | 2008-07-02 | — | — | EP | disclosed |
| WO-2007042546-A1 | IMIDAZOLE DERIVATIVES FOR THE TREATMENT OF ANXIETY AND RELATED DISEASES | NEUROSEARCH A/S (DK) | 2007-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233929-A1 | Imidazole Derivatives for the Treatment of Anxiety and Related Diseases | GABBR1, GABRB2, GABRB3 | PTGES2 1294/4885CNR2 48/4885QPCT 1797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.